4597 Solasia Pharma K.K.ソレイジア・ファーマTSE Growth / Pharmaceuticals
0 posts
Solasia Pharma K.K. stock rose on Nov 19: what happened
It closed at ¥26.0 on Nov 19 (+¥2.0, +8.33%), ranking #20 among the top gainers of all stocks on the Tokyo Stock Exchange.
No disclosures were found for this stock around that day. Share what you know in the posts below.
Changes are calculated from the closing prices this site collects daily; limit-up/down is an estimate based on the daily price limit. Please make your own investment decisions.
Solasia Pharma K.K. (4597) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Solasia Pharma K.K. (4597) Stock Price History
Solasia Pharma K.K. closed at ¥26.0 on Nov 20, 2026, +0.0% over 1 month, −16.1% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥100,000 today (+0.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved +0.0%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥26.0 | +0 | +0.00% |
| Nov 19 (Thu) | ¥26.0 | +2 | +8.33% |
| Nov 18 (Wed) | ¥24.0 | +1 | +4.35% |
| Nov 17 (Tue) | ¥23.0 | −1 | −4.17% |
| Nov 16 (Mon) | ¥24.0 | −1 | −4.00% |
| Nov 13 (Fri) | ¥25.0 | +1 | +4.17% |
| Nov 12 (Thu) | ¥24.0 | −1 | −4.00% |
| Nov 11 (Wed) | ¥25.0 | +2 | +8.70% |
| Nov 9 (Mon) | ¥23.0 | +0 | +0.00% |
| Nov 6 (Fri) | ¥23.0 | −2 | −8.00% |
If you had invested ¥100,000 3 months ago, it would be worth ¥72,222 today (−27.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −27.8%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥26.0 | +0 | +0.00% |
| Nov 19 (Thu) | ¥26.0 | +2 | +8.33% |
| Nov 18 (Wed) | ¥24.0 | +1 | +4.35% |
| Nov 17 (Tue) | ¥23.0 | −1 | −4.17% |
| Nov 16 (Mon) | ¥24.0 | −1 | −4.00% |
| Nov 13 (Fri) | ¥25.0 | +1 | +4.17% |
| Nov 12 (Thu) | ¥24.0 | −1 | −4.00% |
| Nov 11 (Wed) | ¥25.0 | +2 | +8.70% |
| Nov 9 (Mon) | ¥23.0 | +0 | +0.00% |
| Nov 6 (Fri) | ¥23.0 | −2 | −8.00% |
If you had invested ¥100,000 6 months ago, it would be worth ¥104,000 today (+4.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved +4.0%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥26.0 | −3.7% |
| Oct 2026 | ¥27.0 | −10.0% |
| Sep 2026 | ¥30.0 | +0.0% |
| Aug 2026 | ¥30.0 | +7.1% |
| Jul 2026 | ¥28.0 | +7.7% |
| Jun 2026 | ¥26.0 | +0.0% |
| May 2026 | ¥26.0 | −21.2% |
If you had invested ¥100,000 1 year ago, it would be worth ¥83,871 today (−16.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.9%, while this stock moved −16.1%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥26.0 | −3.7% |
| Oct 2026 | ¥27.0 | −10.0% |
| Sep 2026 | ¥30.0 | +0.0% |
| Aug 2026 | ¥30.0 | +7.1% |
| Jul 2026 | ¥28.0 | +7.7% |
| Jun 2026 | ¥26.0 | +0.0% |
| May 2026 | ¥26.0 | −21.2% |
| Apr 2026 | ¥33.0 | +6.5% |
| Mar 2026 | ¥31.0 | −16.2% |
| Feb 2026 | ¥37.0 | +32.1% |
| Jan 2026 | ¥28.0 | −3.4% |
| Dec 2025 | ¥29.0 | −14.7% |
| Nov 2025 | ¥34.0 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥57,778 today (−42.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +68.8%, while this stock moved −42.2%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥26.0 | −10.3% |
| 2025 | ¥29.0 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥24,762 today (−75.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +101.3%, while this stock moved −75.2%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥26.0 | −10.3% |
| 2025 | ¥29.0 | ― |
If you had invested ¥100,000 in Apr 2017, it would be worth ¥4,906 today (−95.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +181.7%, while this stock moved −95.1%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥26.0 | −10.3% |
| 2025 | ¥29.0 | −19.4% |
| 2024 | ¥36.0 | −20.0% |
| 2023 | ¥45.0 | −8.2% |
| 2022 | ¥49.0 | −54.2% |
| 2021 | ¥107 | −7.8% |
| 2020 | ¥116 | −37.0% |
| 2019 | ¥184 | +28.7% |
| 2018 | ¥143 | −63.6% |
| 2017 | ¥393 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Apr 2017). Please check the latest prices before trading.
Solasia Pharma K.K. (4597) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of Solasia Pharma K.K. (4597)
Business overview
The company is a specialty pharma focused on developing and selling cancer drugs in Japan and in Asian countries such as China and South Korea. It in-licenses drug candidates and concentrates on clinical development through to regulatory approval. Besides cancer treatments, it works on drugs and medical devices that reduce side effects from anticancer drugs and radiation therapy.
Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| PBR | 5.27x | Above the sector median of 1.86x (No. 67 from the lowest) |
|---|---|---|
| Market cap | ¥7.1 bn | No. 53 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥41 | 4/20 |
|---|---|---|
| 52-week low | ¥22 | 6/11 |
| Current position | 21.1% | Where the low is 0% and the high is 100% (close on 11/20: ¥26) |
| Year to date | -10.3% | No. 37 of 77 in the sector (best first) |
| 1 year | -16.1% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 6 times | Latest: 11/19 (No. 20) |
|---|---|---|
| Top 50 losers | 2 times | Latest: 10/13 (No. 34) |
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/17 15:50開発品SP-05パートナー企業Isofol社への追加出資(新株予約権行使)のお知らせ
- 11/12 15:302026年12月期 第3四半期決算短信〔IFRS〕(連結)
- 11/12 15:30製品開発品等の事業状況(2026年12月期第3四半期)
- 11/11 16:30当社開発品 SP-05第Ib/II相臨床試験最新情報(権利導入元 Isofol 社情報開示)
- 10/19 16:00ライセンス契約収益(Sancuso分割契約金)計上、および2026年度製品販売収益・売上原価見込値修正のお知らせ
Filings from the past 12 months (5).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the Solasia Pharma K.K. board
More Japanese stocks in English
- Delta-Fly Pharma,Inc.4598
- StemRIM Inc.4599
- Nomura High-yield J-REIT Index ETF459A
- BRANU Inc.460A
- Dai Nippon Toryo Company,Limited4611
- NIPPON PAINT HOLDINGS CO.,LTD.4612
- KANSAI PAINT CO.,LTD.4613
- SHINTO PAINT COMPANY,LIMITED4615
- KAWAKAMI PAINT MANUFACTURING CO.,LTD.4616
- Chugoku Marine Paints,Ltd.4617
- Nihon Tokushu Toryo Co.,Ltd.4619
- MAXIS Japan Equity High Dividend SMART 50 ETF461A